Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)

Overview of attention for article published in Frontiers in oncology, May 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 7 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 6,816 followers.

Frontiers | Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3) | Oncology https://t.co/bjTVEXZ6Nv

09 May 2022

Reply Repost Favourite

📣Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated #Radiotherapy in #BreastCancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3) 👨‍⚕️👩‍⚕️ Sarria GR et al 👉 https://t.co/3LLJearZB8 @SarriaGust

09 May 2022

Reply Repost Favourite

New research: Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3): Purpose To compare the late toxicity… https://t.co/

05 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.